HJIM
NVS icon

Henry James International Management’s Novartis NVS Stock Holding History

Henry James International Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.34M Buy
40,427
+31
+0.1% +$4.65K 1.9% 15
2026
Q1 		$6.17M Sell
40,396
-3,200
-7% -$491K 2.23% 14
2025
Q4 		$6.01M Sell
43,596
-3
-0% -$393 1.89% 15
2025
Q3 		$5.59M Hold
43,599
– – 1.71% 19
2025
Q2 		$5.28M Sell
43,599
-2,400
-5% -$271K 1.73% 20
2025
Q1 		$5.13M Buy
45,999
+16
+0% +$1.7K 1.76% 19
2024
Q4 		$4.47M Buy
45,983
+2
+0% +$213 1.61% 21
2024
Q3 		$5.29M Buy
45,981
+1,245
+3% +$141K 1.84% 17
2024
Q2 		$4.76M Buy
44,736
+9,003
+25% +$904K 1.69% 20
2024
Q1 		$3.46M Buy
35,733
+14,903
+72% +$1.53M 1.07% 30
2023
Q4 		$2.1M Buy
20,830
+6,404
+44% +$618K 0.79% 40
2023
Q3 		$1.47M Buy
14,426
+8,650
+150% +$878K 0.64% 45
2023
Q2 		$583K Hold
5,776
– – 0.25% 74
2023
Q1 		$531K Hold
5,776
– – 0.23% 80
2022
Q4 		$524K Buy
5,776
+2,225
+63% +$187K 0.25% 75
2022
Q3 		$270K Hold
3,551
– – 0.15% 99
2022
Q2 		$300K Hold
3,551
– – 0.15% 102
2022
Q1 		$312K Hold
3,551
– – 0.12% 95
2021
Q4 		$311K Sell
3,551
-8
-0.2% -$664 0.1% 126
2021
Q3 		$291K Hold
3,559
– – 0.09% 129
2021
Q2 		$325K Sell
3,559
-1,400
-28% -$125K 0.09% 140
2021
Q1 		$424K Hold
4,959
– – 0.13% 130
2020
Q4 		$468K Hold
4,959
– – 0.16% 92
2020
Q3 		$431K Sell
4,959
-1,231
-20% -$107K 0.18% 90
2020
Q2 		$541K Sell
6,190
-84
-1% -$7.25K 0.23% 83
2020
Q1 		$517K Buy
6,274
+1
+0% +$89 0.27% 79
2019
Q4 		$594K Hold
6,273
– – 0.23% 98
2019
Q3 		$545K Sell
6,273
-5
-0.1% -$449 0.23% 98
2019
Q2 		$573K Sell
6,278
-872
-12% -$73.8K 0.25% 90
2019
Q1 		$616K Hold
7,150
– – 0.28% 84
2018
Q4 		$550K Buy
7,150
+2,244
+46% +$175K 0.36% 82
2018
Q3 		$379K Buy
+4,906
New +$363K 0.14% 193

Other funds holding NVS

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
GGI
Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Henry James International Management's NVS Position: Q2 2026 in Review

Henry James International Management increased its Novartis (NVS) stake by 0.08% in Q2 2026, buying an estimated $4.65K and bringing the position to 40,427 shares worth $6.34M. The position accounts for 1.9% of the portfolio, ranked #15.

Henry James International Management first reported a position in NVS in Q3 2018 and has held it in 32 quarters since. 719 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Henry James International Management held 40,427 shares of Novartis worth $6.34M as of Q2 2026.
  • Henry James International Management bought 31 Novartis shares in Q2 2026, an estimated $4.65K.
  • Novartis made up 1.9% of Henry James International Management's portfolio in Q2 2026, its #15 holding.
  • Henry James International Management first reported a position in Novartis in Q3 2018 and has held it in 32 quarters since.
  • 719 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Henry James International Management's 13F filing for Q2 2026, filed 9 Jul 2026.